Showing results (71-80 of 166) with videos related to

Sort By:
Pageof 17
Hemasphere|July 9, 2024
Infections in patients with mantle cell lymphomaKossi D Abalo, Sara Ekberg, Therese M L Andersson, et al.
Healthcare (Basel, Switzerland)|September 23, 2022
Tackling Mantle Cell Lymphoma in EuropeDenis Horgan, Jan Walewski, Igor Aurer, et al.
Acta Oncologica (Stockholm, Sweden)|April 3, 2015
Sick leave and disability pension among Swedish testicular cancer survivors according to clinical stage and treatmentCarina Nord, Sven-Erik Olofsson, Ingrid Glimelius, et al.
American Journal of Hematology|March 18, 2020
Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphomaTove Wästerlid, Sara Harrysson, Therese M-L Andersson, et al.
Cancer Reports (Hoboken, N.J.)|July 28, 2021
Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphomaLavanya Lokhande, Venera Kuci Emruli, Christian Winther Eskelund, et al.
British Journal of Haematology|July 16, 2010
Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphomaFrancesco d'Amore, John Radford, Thomas Relander, et al.
American Journal of Hematology|May 18, 2018
Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphomaSara Ekberg, Mats Jerkeman, Per-Ola Andersson, et al.
Blood Advances|January 4, 2018
Crosstalk between ROR1 and BCR pathways defines novel treatment strategies in mantle cell lymphomaHanna Karvonen, David Chiron, Wilhelmiina Niininen, et al.
Hemasphere|August 2, 2023
Nationwide Assessment of Patient Trajectories in Mantle Cell Lymphoma: The Swedish MCLcomplete ProjectMats Jerkeman, Sara Ekberg, Ingrid Glimelius, et al.
Pageof 17